Top 300 Lodi: IBSA Italy is the only pharmaceutical company among the leading companies in the Lodi area

TOP 300 Lodi, the event dedicated to local entrepreneurship promoted by Assolombarda in collaboration with PwC, Banco BPM, and Il Cittadino di Lodi, is back again this year. Following the success of the previous edition, the format confirms the expansion of the ranking from 200 to 300 companies, offering an even more comprehensive overview of the Lodi area economy. 

The dossier highlights companies that have distinguished themselves in terms of growth, solidity, and performance, contributing to the economic development of the entire territory and in various productive sectors.

In this context, for the eighth year in a row, IBSA Italy ranks in the Top Ten, confirming its position as the only pharmaceutical company among the top positions in the ranking.   

This result highlights the company's central role in its success and its ability to achieve increasingly ambitious goals. 

The strategic drivers that are ensuring this success are represented by three key factors: 

• Industrial investments in the Cassina de’ Pecchi and Lodi production sites to support our key technologies such as NAHYCO® Hybrid and FilmTec®.
• Enhancing the value of people and their skills, thanks in part to collaboration with the academic world 
• Sustainability as an absolute principle, as evidenced by the recent publication of the sixth IBSA Sustainability Report, which transparently describes our commitment to protecting the planet and social responsibility. 

The renovation of the antares headquarters, inaugurated last March, played a significant role in this process. This is a major redevelopment project involving the Lodi headquarters and surrounding areas, covering a total surface area of 12,200 m². The project, which involved improving and expanding the workspaces, further strengthens the company's roots in the local area and demonstrates its commitment to generating value and employment in the Lodi area. 

“We are proud to have achieved this important result again in 2025. To make the Top Ten for the eighth year in a row testifies the solidity of our company, founded on innovation, sustainability, and a people-centered approach. This result encourages us to continue our mission with determination and to be a point of reference not only for the pharmaceutical sector but also for the economic and social development of the Lodi area." - says Giuseppe Celiberti, General Manager IBSA Italy.

Its stable position in the ranking highlights IBSA Italy's role as an active partner in local development, committed to strengthening its roots through projects, investments, and collaborations. This shared journey with the local area will continue in the coming years, with the aim of generating lasting value for the community and the entire production system.